{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:50:22Z","timestamp":1790697022880,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd003868.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,4,22]],"date-time":"2016-04-22T00:00:00Z","timestamp":1461283200000}}],"reference-count":189,"publisher":"Wiley","issue":"3","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003868.pub4","type":"journal-article","created":{"date-parts":[[2016,4,22]],"date-time":"2016-04-22T23:20:21Z","timestamp":1461367221000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Oral morphine for cancer pain"],"prefix":"10.1002","volume":"2021","author":[{"given":"Philip J","family":"Wiffen","sequence":"additional","affiliation":[{"name":"Thame UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bee","family":"Wee","sequence":"additional","affiliation":[{"name":"Nuffield Department of Medicine and Sir Michael Sobell House; Churchill Hospital; Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R Andrew","family":"Moore","sequence":"additional","affiliation":[{"name":"Plymouth UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,4,22]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD003868.pub4-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0885-3924(97)00082-1","article-title":"Transdermal fentanyl versus sustained-release oral morphine in cancer","volume":"13","author":"Ahmedzai","year":"1997","journal-title":"Journal of Pain and Symptom Management"},{"issue":"6","key":"10.1002\/14651858.CD003868.pub4-BIB0002|cit2","first-page":"653","article-title":"Control of severe pain with sustained-release morphine tablets versus oral morphine solution","volume":"140","author":"Arkinstall","year":"1989","journal-title":"Canadian Medical Association Journal"},{"issue":"Suppl 11","key":"10.1002\/14651858.CD003868.pub4-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1002\/1097-0142(19890601)63:11<2294::AID-CNCR2820631139>3.0.CO;2-X","article-title":"Analgesic response to single and multiple doses of controlled release morphine tablets and morphine oral solution in cancer patients","volume":"63","author":"Goughnour","year":"1989","journal-title":"Cancer"},{"issue":"1","key":"10.1002\/14651858.CD003868.pub4-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/j.1552-4604.1998.tb04380.x","article-title":"Comparative efficacy and safety of controlled-release morphine suppositories and tablets in cancer pain","volume":"38","author":"Babul","year":"1998","journal-title":"Journal of Clinical Pharmacology"},{"issue":"7","key":"10.1002\/14651858.CD003868.pub4-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0885-3924(92)90018-D","article-title":"A comparative study of controlled-release morphine (CRM) suspension and CRM tablets in chronic cancer pain","volume":"7","author":"Boureau","year":"1992","journal-title":"Journal of Pain and Symptom Management"},{"issue":"2","key":"10.1002\/14651858.CD003868.pub4-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0885-3924(97)00012-2","article-title":"Comparison of a once-a-day sustained-release morphine formulation with standard oral morphine treatment for cancer pain","volume":"14","author":"Broomhead","year":"1997","journal-title":"Journal of Pain and Symptom Management"},{"issue":"10","key":"10.1002\/14651858.CD003868.pub4-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1200\/JCO.1998.16.10.3222","article-title":"Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain","volume":"16","author":"Bruera","year":"1998","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"10.1002\/14651858.CD003868.pub4-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1200\/JCO.2004.03.172","article-title":"Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study","volume":"22","author":"Bruera","year":"2004","journal-title":"Journal of Clinical Oncology"},{"issue":"11 Suppl","key":"10.1002\/14651858.CD003868.pub4-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1002\/1097-0142(19890601)63:11<2355::AID-CNCR2820631147>3.0.CO;2-#","article-title":"Evaluation of a cancer pain model for the testing of long-acting analgesics. The effect of MS Contin in a double-blind, randomized crossover design","volume":"63","author":"Cundiff","year":"1989","journal-title":"Cancer"},{"issue":"Suppl","key":"10.1002\/14651858.CD003868.pub4-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/0885-3924(88)90082-6","article-title":"Evaluation of a controlled- and immediate release morphine and a unique well-controlled study design in cancer pain","volume":"3","author":"Cundiff","year":"1988","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jpainsymman.2006.10.011","article-title":"A randomized, double-blind, multi-site, crossover, placebo-controlled equivalence study of morning versus evening once-daily sustained-release morphine sulfate in people with pain from advanced cancer","volume":"34","author":"Currow","year":"2007","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jpainsymman.2007.12.016","article-title":"A double-blind, randomized, crossover comparison between single-dose and double-dose immediate-release oral morphine at bedtime in cancer patients","volume":"37","author":"Dale","year":"2009","journal-title":"Journal of Pain and Symptom Management"},{"issue":"4","key":"10.1002\/14651858.CD003868.pub4-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1200\/JCO.1995.13.4.1004","article-title":"Role of rectal route in treating cancer pain: a randomized crossover clinical trial of oral versus rectal morphine administration in opioid-naive cancer patients with pain","volume":"13","author":"De Conno","year":"1995","journal-title":"Journal of Clinical Oncology"},{"issue":"9","key":"10.1002\/14651858.CD003868.pub4-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/0959-8049(94)90166-X","article-title":"Medical therapy of malignant nerve pain. A randomised double-blind explanatory trial with naproxen versus slow-release morphine","volume":"30A","author":"Dellemijn","year":"1994","journal-title":"European Journal of Cancer"},{"issue":"7","key":"10.1002\/14651858.CD003868.pub4-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/0885-3924(92)90017-C","article-title":"The evaluation of analgesic effects in cancer patients as exemplified by a double-blind, crossover study of immediate-release versus controlled-release morphine","volume":"7","author":"Deschamps","year":"1992","journal-title":"Journal of Pain and Symptom Management"},{"issue":"4","key":"10.1002\/14651858.CD003868.pub4-BIB0016|cit16","first-page":"521","article-title":"Effects of controlled released morphine on quality of life for cancer pain","volume":"16","author":"Ferrell","year":"1989","journal-title":"Oncology Nursing Forum"},{"issue":"5","key":"10.1002\/14651858.CD003868.pub4-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1200\/JCO.1993.11.5.967","article-title":"Placebo-blinded study of morphine sulfate sustained-release tablets and immediate-release morphine sulfate solution in outpatients with chronic pain due to advanced cancer","volume":"11","author":"Finn","year":"1993","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"10.1002\/14651858.CD003868.pub4-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2165\/00044011-199714030-00004","article-title":"Comparison of two oral morphine formulations for chronic severe pain of malignant and non malignant origin Kapanol (R) vs MST (R)","volume":"14","author":"Fl\u00f6ter","year":"1997","journal-title":"Clinical Drug Investigation"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003868.pub4-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2165\/00044011-199700141-00006","article-title":"Double-blind crossover clinical and pharmacokinetic comparison of oral morphine syrup and sustained release morphine sulfate capsules in patients with cancer-related pain","volume":"14","author":"Gillette","year":"1997","journal-title":"Clinical Drug Investigation"},{"issue":"3","key":"10.1002\/14651858.CD003868.pub4-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0304-3959(96)03269-1","article-title":"Pharmacokinetics and pharmacodynamics of twenty-four-hourly Kapanol compared to twelve-hourly MS Contin in the treatment of severe cancer pain","volume":"69","author":"Gourlay","year":"1997","journal-title":"Pain"},{"issue":"1","key":"10.1002\/14651858.CD003868.pub4-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jpainsymman.2004.04.015","article-title":"Efficacy, safety, and steady state pharmacokinetics of once-a-day controlled release morphine (MS Contin XL) in cancer pain","volume":"29","author":"Hagen","year":"2005","journal-title":"Journal of Pain and Symptom Management"},{"issue":"8","key":"10.1002\/14651858.CD003868.pub4-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1365-2044.1987.tb04107.x","article-title":"Controlled release morphine tablets: a double blind trial in patients with advanced cancer","volume":"42","author":"Hanks","year":"1987","journal-title":"Anaesthesia"},{"issue":"1","key":"10.1002\/14651858.CD003868.pub4-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0885-3924(94)00067-U","article-title":"Efficacy and pharmacokinetics of a new controlled-release morphine sulfate 200-mg tablet","volume":"10","author":"Hanks","year":"1995","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1472-684X-7-17","article-title":"A randomized, double-blind comparison of OROS hydromorphone and controlled-release morphine for the control of chronic cancer pain","volume":"7","author":"Hanna","year":"2008","journal-title":"BMC Palliative Care"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1191\/0269216303pm695oa","article-title":"Intravenous morphine for rapid control of severe cancer pain","volume":"17","author":"Harris","year":"2003","journal-title":"Palliative Medicine"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0304-3959(97)00072-9","article-title":"Controlled-release oxycodone and morphine in cancer related pain","volume":"73","author":"Heiskanen","year":"1997","journal-title":"Pain"},{"issue":"8","key":"10.1002\/14651858.CD003868.pub4-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1080\/02841860050215927","article-title":"Morphine or oxycodone in cancer pain?","volume":"39","author":"Heiskanen","year":"2000","journal-title":"Acta Oncologica"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/1049909109345146","article-title":"A comparative study of 2 sustained-release morphine preparations for pain in advanced cancer","volume":"27","author":"Homsi","year":"2010","journal-title":"American Journal of Hospice and Palliative Care"},{"issue":"11","key":"10.1002\/14651858.CD003868.pub4-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/j.1365-2044.1989.tb09143.x","article-title":"Controlled release morphine in cancer pain. Is a loading dose required when the formulation is changed?","volume":"44","author":"Hoskin","year":"1989","journal-title":"Anaesthesia"},{"issue":"5","key":"10.1002\/14651858.CD003868.pub4-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/clpt.1990.85","article-title":"Morphine and oxycodone hydrochloride in the management of cancer pain","volume":"47","author":"Kalso","year":"1990","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD003868.pub4-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2165\/00044011-200019010-00004","article-title":"A patient preference study comparing two extended-release morphine sulfate formulations (once-daily Kadian\u2122 versus twice-daily MS Contin\u2122) for cancer pain","volume":"19","author":"Kerr","year":"2000","journal-title":"Clinical Drug Investigation"},{"issue":"1-2","key":"10.1002\/14651858.CD003868.pub4-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0304-3959(02)00328-7","article-title":"Immediate- or sustained-release morphine for dose finding during start of morphine to cancer patients: a randomized, double-blind trial","volume":"101","author":"Klepstad","year":"2003","journal-title":"Pain"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0033|cit33","unstructured":"Henriksen H Knudsen J Controlled evaluation and ongoing experience with sustained release morphine in patients with advanced cancer pain Advances in Cancer Pain Management. The International Symposium on Pain Control Toronto Purdue Frederick Inc 1986"},{"issue":"9","key":"10.1002\/14651858.CD003868.pub4-BIB0034|cit34","first-page":"780","article-title":"Slow-release morphine tablets compared with conventional morphine tablets in the treatment of cancer pain","volume":"147","author":"Knudsen","year":"1985","journal-title":"Ugeskrift for Laeger"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0035|cit35","first-page":"73","volume-title":"Advances in Morphine Therapy. The 1983 International Symposium on Pain Control. Royal Society of Medicine International Congress and Symposium Series no 64","author":"Kossman","year":"1983"},{"issue":"11","key":"10.1002\/14651858.CD003868.pub4-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1038\/sj.bjc.6601365","article-title":"Comparison of sustained-release morphine with sustained-release oxycodone in advanced cancer patients","volume":"89","author":"Lauretti","year":"2003","journal-title":"British Journal of Cancer"},{"issue":"3","key":"10.1002\/14651858.CD003868.pub4-BIB0037|cit37","first-page":"257","article-title":"Analgesic efficacy and side effects of oral tramadol and morphine administered orally in the treatment of cancer pain","volume":"51","author":"Leppart","year":"2001","journal-title":"Nowotwory"},{"issue":"4","key":"10.1002\/14651858.CD003868.pub4-BIB0038|cit38","first-page":"435","article-title":"The Brompton mixture versus morphine solution given orally: effects on pain","volume":"120","author":"Melzack","year":"1979","journal-title":"Canadian Medical Association Journal"},{"issue":"2","key":"10.1002\/14651858.CD003868.pub4-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0885-3924(98)80004-3","article-title":"Dextropropoxyphene versus morphine in opioid-naive cancer patients with pain","volume":"15","author":"Mercadante","year":"1998","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.ejpain.2008.01.013","article-title":"Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management","volume":"12","author":"Mercadante","year":"2008","journal-title":"European Journal of Pain"},{"issue":"9","key":"10.1002\/14651858.CD003868.pub4-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/AJP.0b013e3181ecd895","article-title":"Morphine versus oxycodone in pancreatic cancer pain: a randomized controlled study","volume":"26","author":"Mercadante","year":"2010","journal-title":"Clinical Journal of Pain"},{"issue":"6","key":"10.1002\/14651858.CD003868.pub4-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/0885-3924(95)00063-5","article-title":"Control of cancer-related pain with MS Contin: a comparison between 12-hourly and 8-hourly administration","volume":"10","author":"Mignault","year":"1995","journal-title":"Journal of Pain and Symptom Management"},{"issue":"11","key":"10.1002\/14651858.CD003868.pub4-BIB0043|cit43","first-page":"2357","article-title":"Utility evaluation of morphine hydrocloride suppository, AN-631, in the treatment of cancer pain","volume":"6","author":"Mizuguchi","year":"1990","journal-title":"Rinshou Igaku"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0044|cit44","first-page":"1","article-title":"A randomised crossover comparison of controlled release hydromorphone tablets with controlled release morphine tablets in patients with cancer pain","volume":"2","author":"Moriarty","year":"1999","journal-title":"Journal of Clinical Research"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1090-3801(98)90020-9","article-title":"Controlled-release oxycodone compared with controlled-release morphine in the treatment of cancer pain: a randomized, double-blind, parallel-group study","volume":"2","author":"Mucci LoRusso","year":"1998","journal-title":"European Journal of Pain"},{"issue":"6","key":"10.1002\/14651858.CD003868.pub4-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1177\/026921639701100608","article-title":"A randomized crossover study comparing the efficacy and tolerability of a novel once-daily morphine preparation (MXL capsules) with MST Continus tablets in cancer patients with severe pain","volume":"11","author":"O'Brien","year":"1997","journal-title":"Palliative Medicine"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0047|cit47","first-page":"20","article-title":"Comparison of TD-fentanyl with sustained-release morphine in the pain treatment of patients with lung cancer","volume":"20","author":"Ozt\u00fcrk","year":"2008","journal-title":"Agri"},{"issue":"12","key":"10.1002\/14651858.CD003868.pub4-BIB0048|cit48","first-page":"672","article-title":"Comparison of morphine slow release tablet (MST) and morphine sulphate solution (MSS) in the treatment of cancer pain","volume":"76","author":"Panich","year":"1993","journal-title":"Journal of Medical Association of Thailand"},{"issue":"Suppl 11","key":"10.1002\/14651858.CD003868.pub4-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1002\/1097-0142(19890601)63:11<2284::AID-CNCR2820631137>3.0.CO;2-3","article-title":"Oral controlled release morphine sulfate. Analgesic efficacy and side effects of a 100 mg tablet in cancer pain patients","volume":"63","author":"Portenoy","year":"1989","journal-title":"Cancer"},{"issue":"3","key":"10.1002\/14651858.CD003868.pub4-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"Suppl 16","DOI":"10.1016\/0885-3924(88)90076-0","article-title":"Controlled-release morphine sulfate: analgesic efficacy and side effects of a 100 mg tablet","volume":"3","author":"Portenoy","year":"1988","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jpainsymman.2009.08.013","article-title":"Clinical efficacy and safety of once-daily dosing of a novel, prolonged-release oral morphine tablet compared with twice-daily dosing of a standard controlled-release morphine tablet in patients with cancer pain: a randomized, double-blind, exploratory crossover study","volume":"39","author":"Ridgway","year":"2010","journal-title":"Journal of Pain and Symptom Management"},{"issue":"5","key":"10.1002\/14651858.CD003868.pub4-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/0959-8049(94)90524-X","article-title":"Efficacy and tolerance of oral dipyrone versus oral morphine for cancer pain","volume":"30A","author":"Rodriguez","year":"1994","journal-title":"European Journal of Cancer"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD003868.pub4-BIB0053|cit53","first-page":"S55","article-title":"Morphine at gramme doses: kinetics, dynamics and clinical need","volume":"67","author":"Smith","year":"1991","journal-title":"Postgraduate Medical Journal"},{"issue":"Suppl 11","key":"10.1002\/14651858.CD003868.pub4-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1002\/1097-0142(19890601)63:11<2275::AID-CNCR2820631136>3.0.CO;2-4","article-title":"Pharmacokinetics and clinical efficacy of oral morphine solution and controlled-release morphine tablets in cancer patients","volume":"63","author":"Thirlwell","year":"1989","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1191\/0269216302pm591oa","article-title":"An assessment of the efficacy and tolerability of a 'double dose' of normal-release morphine sulphate at bedtime","volume":"16","author":"Todd","year":"2002","journal-title":"Palliative Medicine"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD003868.pub4-BIB0056|cit56","first-page":"58","article-title":"The measurement of pain in terminal carcinoma","volume":"4","author":"Twycross","year":"1976","journal-title":"Journal of International Medical Research"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0304-3959(77)90072-0","article-title":"Choice of strong analgesic in terminal cancer: diamorphine or morphine?","volume":"3","author":"Twycross","year":"1977","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD003868.pub4-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1399-6576.1988.tb02711.x","article-title":"Opioid treatment for radiating cancer pain: oral administration vs. epidural techniques","volume":"32","author":"Vainio","year":"1988","journal-title":"Acta Anaesthesiologica Scandinavica"},{"issue":"6","key":"10.1002\/14651858.CD003868.pub4-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1185\/030079903125002045","article-title":"Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain","volume":"19","author":"Van Seventer","year":"2003","journal-title":"Current Medical Research and Opinion"},{"issue":"4","key":"10.1002\/14651858.CD003868.pub4-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0885-3924(86)80042-2","article-title":"A randomized study on oral administration of morphine and methadone in the treatment of cancer pain","volume":"1","author":"Ventafridda","year":"1986","journal-title":"Journal of Pain and Symptom Management"},{"issue":"3","key":"10.1002\/14651858.CD003868.pub4-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/0885-3924(89)90005-5","article-title":"Clinical observations on controlled release morphine in cancer pain","volume":"4","author":"Ventafridda","year":"1989","journal-title":"Journal of Pain and Symptom Management"},{"issue":"4","key":"10.1002\/14651858.CD003868.pub4-BIB0062|cit62","first-page":"137","article-title":"Sustained release morphine in cancer pain","volume":"9","author":"Vielvoye-Kerkmeer","year":"2002","journal-title":"European Journal of Palliative Care"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0063|cit63","first-page":"99","volume-title":"Advances in Morphine Therapy: International Symposium on Pain Control","author":"Walsh","year":"1984"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0064|cit64","first-page":"727","article-title":"Clinical evaluation of slow release morphine tablets","volume":"9","author":"Walsh","year":"1985","journal-title":"Advances in Pain Research and Therapy"},{"issue":"3","key":"10.1002\/14651858.CD003868.pub4-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/00000421-199206000-00018","article-title":"A controlled study of sustained-release morphine sulfate tablets in chronic pain from advanced cancer","volume":"15","author":"Walsh","year":"1992","journal-title":"American Journal of Clinical Oncology"},{"issue":"2","key":"10.1002\/14651858.CD003868.pub4-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/oxfordjournals.annonc.a058765","article-title":"Oral tramadol, a mu-opioid agonist and monoamine reuptake-blocker, and morphine for strong cancer-related pain","volume":"5","author":"Wilder-Smith","year":"1994","journal-title":"Annals of Oncology"},{"issue":"3","key":"10.1002\/14651858.CD003868.pub4-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF00685556","article-title":"Pharmacokinetics and efficacy of rectal versus oral sustained-release morphine in cancer patients","volume":"31","author":"Wilkinson","year":"1992","journal-title":"Cancer Chemotherapy and Pharmacology"},{"issue":"1","key":"10.1002\/14651858.CD003868.pub4-BIB0068|cit68","first-page":"25","article-title":"Comparison of oral controlled-release morphine with transdermal fentanyl in terminal cancer pain","volume":"35","author":"Wong","year":"1997","journal-title":"Acta Anaesthesiologica Sinica"},{"issue":"1","key":"10.1002\/14651858.CD003868.pub4-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2165\/00044011-199700141-00008","article-title":"Clinical evaluation of the analgesic effect of sustained release morphine sulfate microgranules in patients with terminal cancer","volume":"Suppl 14","author":"Xu","year":"1997","journal-title":"Clinical Drug Investigation"},{"issue":"7","key":"10.1002\/14651858.CD003868.pub4-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/0885-3924(92)90019-E","article-title":"Pharmacokinetics of two novel rectal controlled-release morphine formulations","volume":"7","author":"Babul","year":"1992","journal-title":"Journal of Pain and Symptom Management"},{"issue":"4","key":"10.1002\/14651858.CD003868.pub4-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1177\/009127007701700402","article-title":"Comparisons of the analgesic effects of oral and intramuscular oxymorphone and of intramuscular oxymorphone and morphine in patients with cancer","volume":"17","author":"Beaver","year":"1977","journal-title":"Journal of Clinical Pharmacology"},{"issue":"1","key":"10.1002\/14651858.CD003868.pub4-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0022-3565(25)31396-0","article-title":"Analgesic studies of codeine and oxycodone in patients with cancer. I. Comparisons of oral with intramuscular codeine and of oral with intramuscular oxycodone","volume":"207","author":"Beaver","year":"1978","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD003868.pub4-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/00002508-199412000-00012","article-title":"Comparison of morphine and ketorolac for intravenous patient-controlled analgesia in postoperative cancer patients","volume":"10","author":"Bosek","year":"1994","journal-title":"Clinical Journal of Pain"},{"issue":"3","key":"10.1002\/14651858.CD003868.pub4-BIB0074|cit74","first-page":"275","article-title":"Principles of cancer pain management. Use of long-acting oral morphine","volume":"28","author":"Brooks","year":"1989","journal-title":"Journal of Family Practice"},{"issue":"2","key":"10.1002\/14651858.CD003868.pub4-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2165\/00044011-199714020-00008","article-title":"Comparative bioavailability of sustained-release morphine sulfate capsules versus pellets","volume":"14","author":"Broomhead","year":"1997","journal-title":"Clinical Drug Investigation"},{"issue":"6","key":"10.1002\/14651858.CD003868.pub4-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1200\/JCO.1995.13.6.1520","article-title":"Clinical efficacy and safety of a novel controlled-release morphine suppository and subcutaneous morphine in cancer pain: a randomized evaluation","volume":"13","author":"Bruera","year":"1995","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0077|cit77","first-page":"132","volume-title":"International Symposium on Pain Control. Royal Society of Medicines Services International Congress and Symposium Series 123","author":"Buxton","year":"1987"},{"issue":"3","key":"10.1002\/14651858.CD003868.pub4-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/j.1875-9114.1990.tb02577.x","article-title":"A multiinstitutional evaluation of the analgesic efficacy and safety of ketorolac tromethamine, acetaminophen plus codeine, and placebo in cancer pain","volume":"10","author":"Carlson","year":"1990","journal-title":"Pharmacotherapy"},{"issue":"5","key":"10.1002\/14651858.CD003868.pub4-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1212\/WNL.44.5.857","article-title":"Opioid responsiveness of cancer pain syndromes caused by neuropathic or nociceptive mechanisms: a combined analysis of controlled, single-dose studies","volume":"44","author":"Cherny","year":"1994","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"Suppl 29","DOI":"10.1213\/00000539-198702001-00029","article-title":"Morphine inhalation versus intravenous infusion in pain treatment after abdominal surgery","volume":"66","author":"Chrubasik","year":"1987","journal-title":"Anesthesia and Analgesia"},{"issue":"5","key":"10.1002\/14651858.CD003868.pub4-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3109\/07357909209024792","article-title":"Patient-controlled analgesia for cancer pain: a long-term study of inpatient and outpatient use","volume":"10","author":"Citron","year":"1992","journal-title":"Cancer Investigation"},{"issue":"3","key":"10.1002\/14651858.CD003868.pub4-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/0893-133X(95)00205-R","article-title":"Effects of oral morphine on cold pressor tolerance time and neuropsychological performance","volume":"15","author":"Cleeland","year":"1996","journal-title":"Neuropsychopharmacology"},{"issue":"1-2","key":"10.1002\/14651858.CD003868.pub4-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0304-3959(00)00427-9","article-title":"Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR)","volume":"91","author":"Coluzzi","year":"2001","journal-title":"Pain"},{"issue":"1","key":"10.1002\/14651858.CD003868.pub4-BIB0084|cit84","first-page":"26","article-title":"Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR)","volume":"3","author":"Coluzzi","year":"2002","journal-title":"Douleurs"},{"issue":"5","key":"10.1002\/14651858.CD003868.pub4-BIB0085|cit85","first-page":"306","article-title":"Irruptive pain in cancer: A randomized comparative trial of oral transmucosal fentanyl citrate (OTFC) versus immediate-release morphine sulphate (MSIR)","volume":"9","author":"Coluzzi","year":"2002","journal-title":"Revista De La Sociedad Espanola Del Dolor"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0086|cit86","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/j.1526-4637","article-title":"An exploratory analysis on the effectiveness of four strong opioids in patients with cancer pain","volume":"13","author":"Corli","year":"2012","journal-title":"Pain Medicine"},{"issue":"4","key":"10.1002\/14651858.CD003868.pub4-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0360-3016(97)00076-X","article-title":"Low energy helium-neon laser in the prevention of oral mucositis in the prevention of oral mucositis in patients undergoing bone marrow transplant: results of a double blind randomized trial","volume":"38","author":"Cowen","year":"1997","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"1","key":"10.1002\/14651858.CD003868.pub4-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/0742-969X.1993.11882756","article-title":"Comparative morphine pharmacokinetics following sublingual, intramuscular, and oral administration in patients with cancer","volume":"9","author":"Davis","year":"1993","journal-title":"Hospice Journal"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003868.pub4-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2165\/00044011-199700141-00007","article-title":"Randomised crossover comparison of the pharmacokinetic profiles of two sustained release morphine sulfate formulations in patients with cancer-related pain","volume":"14","author":"De Bernardi","year":"1997","journal-title":"Clinical Drug Investigation"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0090|cit90","first-page":"49","article-title":"Analgesic efficacy and side effects of opioids in different routes of administration for terminal cancer patients: a clinical, pharmacokinetic and neurophysiological study","volume":"13","author":"De Conno","year":"1997","journal-title":"Journal of Clinical Oncology"},{"issue":"6","key":"10.1002\/14651858.CD003868.pub4-BIB0091|cit91","first-page":"356","article-title":"The steady-state concentration of morphine sulphate tablets and its clinical analgesic effect in cancer patients","volume":"32","author":"Deng","year":"1997","journal-title":"Chinese Pharmaceutical Journal"},{"issue":"3","key":"10.1002\/14651858.CD003868.pub4-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0885-3924(97)00361-8","article-title":"Long-term treatment of cancer pain with transdermal fentanyl","volume":"15","author":"Donner","year":"1998","journal-title":"Journal of Pain and Symptom Management"},{"issue":"2","key":"10.1002\/14651858.CD003868.pub4-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0304-3959(89)90020-1","article-title":"Treatment of severe cancer pain by low-dose continuous subcutaneous morphine","volume":"36","author":"Drexel","year":"1989","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD003868.pub4-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/00007691-199904000-00011","article-title":"The influence of the route of administration: a comparative study at steady state of oral sustained release morphine and morphine sulfate suppositories","volume":"21","author":"Du","year":"1999","journal-title":"Therapeutic Drug Monitoring"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jpainsymman.2006.09.017","article-title":"A phase III randomized, double-blind, placebo-controlled study evaluating dextromethorphan plus slow-release morphine for chronic cancer pain relief in terminally ill patients","volume":"33","author":"Dudgeon","year":"2007","journal-title":"Journal of Pain and Symptom Management"},{"issue":"1","key":"10.1002\/14651858.CD003868.pub4-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/0885-3924(92)90101-M","article-title":"A double-blind, crossover trial of intravenous clodronate in metastatic bone pain","volume":"7","author":"Ernst","year":"1992","journal-title":"Journal of Pain and Symptom Management"},{"issue":"8","key":"10.1002\/14651858.CD003868.pub4-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/jnci\/90.8.611","article-title":"Oral transmucosal fentanyl citrate: randomized, double-blinded, placebo-controlled trial for treatment of breakthrough pain in cancer patients","volume":"90","author":"Farrar","year":"1998","journal-title":"Journal of the National Cancer Institute"},{"issue":"2","key":"10.1002\/14651858.CD003868.pub4-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0885-3924(95)00148-4","article-title":"Morphine and morphine-6-glucuronide plasma concentrations and effect in cancer pain","volume":"11","author":"Faura","year":"1996","journal-title":"Journal of Pain and Symptom Management"},{"issue":"4","key":"10.1002\/14651858.CD003868.pub4-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/026921639300700407","article-title":"A novel morphine sulphate preparation: clinical trial of a controlled-release morphine suspension in cancer pain","volume":"7","author":"Forman","year":"1993","journal-title":"Palliative Medicine"},{"issue":"7","key":"10.1002\/14651858.CD003868.pub4-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1177\/000348940010900711","article-title":"Cervical versus thoracic epidural morphine for the treatment of head and neck cancer pain","volume":"109","author":"Georgiou","year":"2000","journal-title":"Annals of Otology, Rhinology & Laryngology"},{"issue":"5","key":"10.1002\/14651858.CD003868.pub4-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1200\/JCO.1993.11.5.973","article-title":"Dose-ranging study of oxycodone for chronic pain in advanced cancer","volume":"11","author":"Glare","year":"1993","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"10.1002\/14651858.CD003868.pub4-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0304-3959(86)90234-4","article-title":"A comparative study of the efficacy and pharmacokinetics of oral methadone and morphine in the treatment of severe pain in patients with cancer","volume":"25","author":"Gourlay","year":"1986","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD003868.pub4-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0304-3959(94)00204-R","article-title":"Chronopharmacokinetic variability in plasma morphine concentrations following oral doses of morphine solution","volume":"61","author":"Gourlay","year":"1995","journal-title":"Pain"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/026921639000400307","article-title":"Evaluation of the palatability of Oramorph - a proprietary preparation of oral morphine sulphate","volume":"4","author":"Griffith","year":"1990","journal-title":"Palliative Medicine"},{"issue":"1","key":"10.1002\/14651858.CD003868.pub4-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/j.1552-4604.1995.tb04743.x","article-title":"Steady-state pharmacokinetics of hydromorphone and hydromorphone-3-glucuronide in cancer patients after immediate and controlled-release hydromorphone","volume":"35","author":"Hagen","year":"1995","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/0304-3959(84)90730-9","article-title":"Controlled release morphine tablets in chronic cancer pain","volume":"Suppl","author":"Hanks","year":"1984","journal-title":"Pain"},{"issue":"6","key":"10.1002\/14651858.CD003868.pub4-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/BF00279975","article-title":"Single dose and steady state kinetics of morphine and its metabolites in cancer patients - a comparison of two oral formulations","volume":"40","author":"Hasselstrom","year":"1991","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD003868.pub4-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0304-3959(90)90062-I","article-title":"Self-administration of morphine in bone marrow transplant patients reduces drug requirement","volume":"40","author":"Hill","year":"1990","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD003868.pub4-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0304-3959(92)90235-4","article-title":"Patient-controlled analgesic infusions: alfentanil versus morphine","volume":"49","author":"Hill","year":"1992","journal-title":"Pain"},{"issue":"6","key":"10.1002\/14651858.CD003868.pub4-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3109\/07357909709047595","article-title":"A pharmacodynamic study of morphine and its glucuronide metabolites after single morphine dosing in cancer patients with pain","volume":"15","author":"Hoffman","year":"1997","journal-title":"Cancer Investigation"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0304-3959(81)90506-6","article-title":"Analgesic assay of oral zomepirac and intramuscular morphine in advanced cancer patients","volume":"Suppl","author":"Houde","year":"1981","journal-title":"Pain"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0112|cit112","first-page":"254","article-title":"Relative analgesic potency of intramuscular heroin and morphine in cancer patients with postoperative pain: a preliminary report","volume":"27","author":"Kaiko","year":"1979","journal-title":"National Institute on Drug Abuse Research Monograph"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0113|cit113","first-page":"205","article-title":"Oral fenoprofen compared to intramuscular morphine and oral aspirin in cancer patients with postoperative pain","volume":"49","author":"Kaiko","year":"1984","journal-title":"National Institute on Drug Abuse Research Monograph"},{"issue":"1","key":"10.1002\/14651858.CD003868.pub4-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0304-3959(87)90004-2","article-title":"Cocaine and morphine interaction in acute and chronic cancer pain","volume":"31","author":"Kaiko","year":"1987","journal-title":"Pain"},{"issue":"Suppl 11","key":"10.1002\/14651858.CD003868.pub4-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1002\/1097-0142(19890601)63:11<2348::AID-CNCR2820631146>3.0.CO;2-V","article-title":"The United States experience with oral controlled release morphine (MS Contin tablets). Parts I and II. Review of nine dose titration studies and clinical pharmacology of 15 mg, 30 mg, 60 mg, and 100 mg tablet strengths in normal subjects","volume":"63","author":"Kaiko","year":"1989","journal-title":"Cancer"},{"issue":"2-3","key":"10.1002\/14651858.CD003868.pub4-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0304-3959(96)03161-2","article-title":"Epidural and subcutaneous morphine in the management of cancer pain: a double-blind cross-over study","volume":"67","author":"Kalso","year":"1996","journal-title":"Pain"},{"issue":"6","key":"10.1002\/14651858.CD003868.pub4-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1200\/JCO.1987.5.6.956","article-title":"Controlled release oral morphine sulfate in the treatment of cancer pain with pharmacokinetic correlation","volume":"5","author":"Khojasteh","year":"1987","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"10.1002\/14651858.CD003868.pub4-BIB0118|cit118","first-page":"259","article-title":"Preemptive analgesia on postmastectomy pain syndrome with ibuprofen-arginine","volume":"84","author":"Lakdja","year":"1997","journal-title":"Bulletin Du Cancer"},{"issue":"6","key":"10.1002\/14651858.CD003868.pub4-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1097\/00000542-199906000-00005","article-title":"Oral ketamine and transdermal nitroglycerin as analgesic adjuvants to oral morphine therapy for cancer pain management","volume":"90","author":"Lauretti","year":"1999","journal-title":"Anesthesiology"},{"issue":"4","key":"10.1002\/14651858.CD003868.pub4-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/0742-969X.1990.11882680","article-title":"A multi investigator clinical evaluation of oral controlled release morphine (MS Contin tablets) administered to cancer patients","volume":"6","author":"Lazarus","year":"1990","journal-title":"Hospice Journal"},{"issue":"4","key":"10.1002\/14651858.CD003868.pub4-BIB0121|cit121","first-page":"289","article-title":"Combined traditional Chinese medicine and Western medicine. Relieving effects of Chinese herbs, ear-acupuncture and epidural morphine on postoperative pain in liver cancer","volume":"107","author":"Li","year":"1994","journal-title":"Chinese Medical Journal"},{"issue":"5","key":"10.1002\/14651858.CD003868.pub4-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jpainsymman.2003.10.006","article-title":"Use of strong opioids in advanced cancer pain: a randomized trial","volume":"27","author":"Marinangeli","year":"2004","journal-title":"Journal of Pain and Symptom Management"},{"issue":"4","key":"10.1002\/14651858.CD003868.pub4-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1042\/cs0880447","article-title":"Effects of inhaled nebulized morphine on ventilation and breathlessness during exercise in healthy man","volume":"88","author":"Masood","year":"1995","journal-title":"Clinical Science"},{"issue":"3","key":"10.1002\/14651858.CD003868.pub4-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1365-2125.1996.tb00192.x","article-title":"Systemic absorption of nebulized morphine compared with oral morphine in healthy subjects","volume":"41","author":"Masood","year":"1996","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD003868.pub4-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/j.1552-4604.1987.tb02177.x","article-title":"Management of cancer pain with oral controlled-release morphine sulfate","volume":"27","author":"Meed","year":"1987","journal-title":"Journal of Clinical Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD003868.pub4-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0304-3959(89)90021-3","article-title":"Double-blind evaluation of analgesic efficacy of orally administered diclofenac, nefopam, and acetylsalicylic acid (ASA) plus codeine in chronic cancer pain","volume":"36","author":"Minotti","year":"1989","journal-title":"Pain"},{"issue":"2-3","key":"10.1002\/14651858.CD003868.pub4-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0304-3959(97)00157-7","article-title":"Double-blind evaluation of short-term analgesic efficacy of orally administered diclofenac, diclofenac plus codeine, and diclofenac plus imipramine in chronic cancer pain","volume":"74","author":"Minotti","year":"1998","journal-title":"Pain"},{"issue":"12","key":"10.1002\/14651858.CD003868.pub4-BIB0128|cit128","first-page":"576","article-title":"Prolonged release of morphine alkaloid from a lipophilic suppository base in vitro and in vivo","volume":"30","author":"Morgan","year":"1992","journal-title":"International Journal of Clinical Pharmacology,Therapy and Toxicology"},{"issue":"8995","key":"10.1002\/14651858.CD003868.pub4-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0140-6736(96)90339-6","article-title":"Randomised trial of oral morphine for chronic non-cancer pain","volume":"347","author":"Moulin","year":"1996","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0130|cit130","unstructured":"Methadone versus morphine for cancer-related pain https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00573937 2010"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0131|cit131","unstructured":"A randomized study of optimal pain management: standard pain control versus early intervention with intrathecal therapy in patients with advanced pancreatic cancer https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00660348 2014"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0132|cit132","unstructured":"Fisch M Bearden J (lead investigators) A randomized comparison of oral methadone as a \"first-switch\" opioid versus opioid switching between sustained-release morphine and oxycodone for oncology-hematology outpatients with pain management problems: the \"simply rotate\" study https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00726830 2010"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1089\/jpm.2012.0164","article-title":"Morphine as the first drug for treatment of cancer pain","volume":"15","author":"Nunes","year":"2012","journal-title":"Journal of Palliative Medicine"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0134|cit134","unstructured":"Morphine as the first drug for the treatment of cancer pain https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01541124 2010"},{"issue":"1","key":"10.1002\/14651858.CD003868.pub4-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0304-3959(92)90182-B","article-title":"Octreotide: a potent new non-opiate analgesic for intrathecal infusion","volume":"49","author":"Penn","year":"1992","journal-title":"Pain"},{"issue":"2-3","key":"10.1002\/14651858.CD003868.pub4-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0304-3959(98)00179-1","article-title":"Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study","volume":"79","author":"Portenoy","year":"1999","journal-title":"Pain"},{"issue":"10","key":"10.1002\/14651858.CD003868.pub4-BIB0137|cit137","first-page":"91","article-title":"Tramadol and the possibilities for its use with cancer patients","volume":"64","author":"Repas","year":"1992","journal-title":"Terapevticheskii Arkhiv"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0138|cit138","first-page":"397","volume-title":"Proceedings of the Annual Meeting of the American Society of Clinical Oncology","author":"Ripamonti","year":"1992"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0304-3959(96)03186-7","article-title":"Nimodipine fails to enhance the analgesic effect of slow release morphine in the early phases of cancer pain treatment","volume":"68","author":"Roca","year":"1996","journal-title":"Pain"},{"issue":"1-2","key":"10.1002\/14651858.CD003868.pub4-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0304-3959(98)00019-0","article-title":"Nimodipine-enhanced opiate analgesia in cancer patients requiring morphine dose escalation: a double-blind, placebo-controlled study","volume":"76","author":"Santillan","year":"1998","journal-title":"Pain"},{"issue":"4","key":"10.1002\/14651858.CD003868.pub4-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/clpt.1988.46","article-title":"Rescue factor: a design for evaluating long-acting analgesics","volume":"43","author":"Savarese","year":"1988","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/BF00609900","article-title":"Steady-state kinetics and analgesic effect of oral morphine in cancer patients","volume":"24","author":"S\u00e4we","year":"1983","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"11","key":"10.1002\/14651858.CD003868.pub4-BIB0143|cit143","first-page":"689","article-title":"Intrathecal morphine for postoperative pain","volume":"41","author":"Schaer","year":"1992","journal-title":"Der Anaesthesist"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0144|cit144","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/jjco\/hyu182","article-title":"Efficacy and safety of sublingual fentanyl orally disintegrating tablet at doses determined from oral morphine rescue doses in the treatment of breakthrough cancer pain","volume":"45","author":"Shimoyama","year":"2015","journal-title":"Japanese Journal of Clinical Oncology"},{"issue":"1","key":"10.1002\/14651858.CD003868.pub4-BIB0145|cit145","first-page":"25","article-title":"High-dose epidural opioid treatment of malignant pain","volume":"151","author":"Sjogren","year":"1989","journal-title":"Ugeskrift for Laeger"},{"issue":"2","key":"10.1002\/14651858.CD003868.pub4-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0885-3924(98)00044-X","article-title":"A clinical evaluation of transdermal therapeutic system fentanyl for the treatment of cancer pain","volume":"16","author":"Sloan","year":"1998","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0304-3959(81)90320-1","article-title":"Comparison of the analgesic effect of parenteral levonantradol to morphine and placebo in patients with moderate to severe pain of cancer","volume":"Suppl","author":"Stambaugh","year":"1981","journal-title":"Pain"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0148|cit148","first-page":"838","article-title":"Comparison of immediate vs. sustained released oral morphine in cancer patients - acute pain novel study design","volume":"30","author":"Stambaugh","year":"1990","journal-title":"Journal of Clinical Pharmacology"},{"issue":"5","key":"10.1002\/14651858.CD003868.pub4-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1177\/00912700122010375","article-title":"Double-blind, randomized comparison of the analgesic and pharmacokinetic profiles of controlled- and immediate-release oral oxycodone in cancer pain patients","volume":"41","author":"Stambaugh","year":"2001","journal-title":"Journal of Clinical Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD003868.pub4-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/026921639601000208","article-title":"An investigation of the ability of oral naloxone to correct opioid-related constipation in patients with advanced cancer","volume":"10","author":"Sykes","year":"1996","journal-title":"Palliative Medicine"},{"issue":"17","key":"10.1002\/14651858.CD003868.pub4-BIB0151|cit151","first-page":"6889","article-title":"A clinical evaluation of S-8114 (morphine sulphate controlled-release tablets) in the management of cancer pain: comparison with oral morphine hydrochloride","volume":"21","author":"Takeda","year":"1987","journal-title":"Kiso to Rinsho (The Clinical Report)"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"S377","DOI":"10.1016\/0304-3959(90)92870-V","article-title":"Tramadol hydrochloride in the relief of cancer pain. A double blind comparison against sustained release morphine","volume":"Suppl","author":"Tawfik","year":"1990","journal-title":"Pain"},{"issue":"4","key":"10.1002\/14651858.CD003868.pub4-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/j.1552-4604.1980.tb01705.x","article-title":"Relative analgesic potency of oral zomepirac and intramuscular morphine in cancer patients with postoperative pain","volume":"20","author":"Wallenstein","year":"1980","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"S202","DOI":"10.1016\/0304-3959(84)90432-9","article-title":"Controlled study of slow release morphine for chronic pain in advanced cancer","volume":"Suppl","author":"Walsh","year":"1984","journal-title":"Pain"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0155|cit155","doi-asserted-by":"crossref","unstructured":"Walsh TD Controlled study of oral slow release morphine in pain due to advanced cancer Proceedings of the Annual Meeting of the American Society of Clinical Oncology ASCO 1985 Abs No 1035","DOI":"10.1016\/0304-3959(84)90432-9"},{"issue":"1","key":"10.1002\/14651858.CD003868.pub4-BIB0156|cit156","first-page":"53","article-title":"Analgesia with oral narcotics and added ibuprofen in cancer patients","volume":"4","author":"Weingart","year":"1985","journal-title":"Clinical Pharmacy"},{"issue":"5","key":"10.1002\/14651858.CD003868.pub4-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/00007691-199310000-00003","article-title":"Morphine pharmacokinetics and effects on salivation and continuous reaction times in healthy volunteers","volume":"15","author":"Westerling","year":"1993","journal-title":"Therapeutic Drug Monitoring"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0158|cit158","unstructured":"RCT comparing the analgesic efficacy of 4 therapeutic strategies based on 4 different major opioids (fentanyl, oxycodone, buprenorphine vs morphine) in cancer patients with moderate\/severe pain, at the moment of starting 3rd step of WHO analgesic ladder (CERP) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01809106 2014"},{"issue":"5","key":"10.1002\/14651858.CD003868.pub4-BIB0159|cit159","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1177\/0269216310392102","article-title":"Is oral morphine still the first choice opioid for moderate to severe cancer pain? A systematic review within the European Palliative Care Research Collaborative guidelines project","volume":"25","author":"Caraceni","year":"2011","journal-title":"Palliative Medicine"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0885-3924(98)00094-3","article-title":"Peak plasma concentrations after oral morphine - a systematic review","volume":"16","author":"Collins","year":"1998","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/bmj.310.6977.452","article-title":"The number needed to treat: a clinically useful measure of treatment effect","volume":"310","author":"Cook","year":"1995","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0304-3959(97)00142-5","article-title":"Systematic review of factors affecting the ratios of morphine and its major metabolites","volume":"74","author":"Faura","year":"1998","journal-title":"Pain"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0163|cit163","volume-title":"Management of cancer pain. Evidence report\/Technology Assessment No 35 ARHQ Publication No 02-E002","author":"Goudas","year":"2001"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0164|cit164","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780192632340.001.0001","volume-title":"Oxford Textbook of Clinical Pharmacology and Drug Therapy","author":"Grahame-Smith","year":"2002"},{"issue":"10","key":"10.1002\/14651858.CD003868.pub4-BIB0165|cit165","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010270.pub2","article-title":"Transdermal fentanyl for cancer pain","author":"Hadley","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0166|cit166","unstructured":"Higgins JPT Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"2","key":"10.1002\/14651858.CD003868.pub4-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.pain.2009.09.017","article-title":"How do changes in\u00a0pain\u00a0severity levels correspond to changes in health status and function in patients with painful\u00a0diabetic\u00a0peripheral\u00a0neuropathy?","volume":"149","author":"\u00a0Sadosky","year":"2010","journal-title":"Pain"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0304-3959(96)03033-3","article-title":"Developing a database of published reports of randomised clinical trials in pain research","volume":"66","author":"Jadad","year":"1996","journal-title":"Pain"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7326\/0003-4819-107-2-224","article-title":"Meta-analysis in clinical research","volume":"107","author":"L'Abb\u00e9","year":"1987","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0171|cit171","unstructured":"Mandal A Morphine pharmacology http:\/\/www.news-medical.net\/health\/Morphine-Pharmacology.aspx"},{"issue":"3","key":"10.1002\/14651858.CD003868.pub4-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0304-3959(98)00140-7","article-title":"Size is everything--large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects","volume":"78","author":"Moore","year":"1998","journal-title":"Pain"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0173|cit173","first-page":"15","volume-title":"Systematic Reviews in Pain Research: Methodology Refined","author":"Moore","year":"2008"},{"issue":"7","key":"10.1002\/14651858.CD003868.pub4-BIB0174|cit174","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.pain.2010.05.011","article-title":"\"Evidence\" in chronic pain--establishing best practice in the reporting of systematic reviews","volume":"14","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD003868.pub4-BIB0175|cit175","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.pain.2009.08.007","article-title":"Clinical effectiveness: an approach to clinical trial design more relevant to clinical practice, acknowledging the importance of individual differences","volume":"149","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD003868.pub4-BIB0176|cit176","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.pain.2010.02.039","article-title":"Fibromyalgia: moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain","volume":"149","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"6","key":"10.1002\/14651858.CD003868.pub4-BIB0177|cit177","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/EJA.0b013e328343c569","article-title":"Mean analgesic consumption is inappropriate for testing analgesic efficacy in post-operative pain: analysis and alternative suggestion","volume":"28","author":"Moore","year":"2011","journal-title":"European Journal of Anaesthesiology"},{"issue":"12","key":"10.1002\/14651858.CD003868.pub4-BIB0178|cit178","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008242.pub2","article-title":"Amitriptyline for neuropathic pain and fibromyalgia in adults","author":"Moore","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD003868.pub4-BIB0179|cit179","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/anae.12148","article-title":"Pain measures and cut-offs - 'no worse than mild pain' as a simple, universal outcome","volume":"68","author":"Moore","year":"2013","journal-title":"Anaesthesia"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0180|cit180","doi-asserted-by":"publisher","first-page":"f2690","DOI":"10.1136\/bmj.f2690","article-title":"Expect analgesic failure; pursue analgesic success","volume":"346","author":"Moore","year":"2013","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0181|cit181","doi-asserted-by":"publisher","first-page":"c3515","DOI":"10.1136\/bmj.c3515.","article-title":"Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study","volume":"341","author":"N\u00fcesch","year":"2010","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0182|cit182","volume-title":"Martindale. The Complete Drug Reference","year":"1999"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0183|cit183","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0140-6736(99)01310-0","article-title":"Management of cancer pain","volume":"353","author":"Portenoy","year":"1999","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD003868.pub4-BIB0184|cit184","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003447","article-title":"Hydromorphone for acute and chronic pain","author":"Quigley","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0185|cit185","unstructured":"Review Manager (RevMan) The Nordic Cochrane Centre, The Cochrane Collaboration 2014"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0186|cit186","volume-title":"History of Pain","author":"Rey","year":"1993"},{"issue":"2","key":"10.1002\/14651858.CD003868.pub4-BIB0187|cit187","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003870.pub5","article-title":"Oxycodone for cancer-related pain","author":"Schmidt-Hansen","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0188|cit188","volume-title":"Cancer Pain Relief","author":"World Health Organization","year":"1986"},{"key":"10.1002\/14651858.CD003868.pub4-BIB0189|cit189","unstructured":"World Health Organization WHO Essential Medicines List 17th Edition whqlibdoc.who.int\/hq\/2011\/a95053_eng.pdf"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD003868.pub4\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T21:22:33Z","timestamp":1748899353000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003868.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Pain, Palliative and Supportive Care Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,4,22]]},"references-count":189,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003868.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,22]]}}}